Lonza in Deal with Crucell for Cell Culture Medium

Lonza says it has entered into a co-exclusive global manufacturing, sales and distribution agreement with biopharmaceutical company Crucell (Leiden, Netherlands) for Permexcis, a cell culture medium developed by Crucell for PER.C6 cells. According to the agreement, Lonza will manufacture, market and sell the medium globally. Financial details of the deal were not disclosed. The Permexcis medium is a chemically defined cell culture medium that does not contain human-derived or animal-derived components. Permexcis medium was developed for the cultivation of PER.C6...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers